Validation and standardization of IS900 and F57 real-time quantitative PCR assays for the specific detection and quantification of Mycobacterium avium subsp. paratuberculosis. by Sidoti, Francesca et al.
14 December 2021
AperTO - Archivio Istituzionale Open Access dell'Università di Torino
Original Citation:
Validation and standardization of IS900 and F57 real-time quantitative PCR assays for the specific detection and





(Article begins on next page)
Anyone can freely access the full text of works made available as "Open Access". Works made available under a
Creative Commons license can be used according to the terms and conditions of said license. Use of all other works
requires consent of the right holder (author or publisher) if not exempted from copyright protection by the applicable law.
Availability:
This is the author's manuscript






This is an author version of the contribution published on: 5 
Questa è la versione dell’autore dell’opera: 6 
 [Can J Microbiol. 2011 May;57(5):347-54. doi: 10.1139/W11-022.] 7 
The definitive version is available at: 8 














Validation and standardisation of IS900 and F57 real time qPCR 22 
assays for the specific detection and quantification of Mycobacterium 23 
avium subsp. paratuberculosis. 24 
 25 
Francesca Sidoti a b, Giuliana Banche c, Sara Astegiano b, Valeria Allizond c, Anna Maria Cuffini c, 26 
Massimiliano Bergallo a b. 27 
 28 
francesca.sidoti@unito.it; giuliana.banche@unito.it; sara.astegiano@unito.it; 29 
valeria.allizond@unito.it; annamaria.cuffini@unito.it; massimiliano.bergallo@unito.it  30 
 31 
a Department of Public Health and Microbiology, Virology Unit, Turin University, Italy. 32 
b S. C. Virology U. A.O.U. San Giovanni Battista, Turin, Italy. 33 
cDepartment of Public Health and Microbiology, Bacteriology and Mycology Unit, Turin      34 
University, Italy. 35 
 36 
 37 
Corresponding Author:  38 
Dr. Francesca Sidoti 39 
Department of Public Health and Microbiology, Virology Unit, 40 
University of Turin, Via Santena 9 - 10126 Turin, (Italy). 41 
S. C. Virology U. A.O.U. San Giovanni Battista, Turin, (Italy). 42 
Phone: +39/011/670.5630 - Fax +39/011/670.5648 43 





Mycobacterium avium subspecies paratuberculosis (Map) is the causative agent of  Johne’s disease 48 
(JD), and may contribute to the onset and development of Crohn’s disease (CD) in humans. Due to 49 
its reported isolation from pasteurised milk and the potential for transmission of Map through 50 
environmental sources, rapid detection is fundamental. In this study, we developed two independent 51 
real time quantitative PCR (qPCR) assays targeting IS900 genetic insertion sequence and F57 52 
sequence which proved able to detect  and quantify Map DNA. Validation and standardisation of 53 
the developed methods were performed by evaluating diagnostic trueness, precision and accuracy of 54 
the techniques. Specificity of the IS900 and F57 methods was verified both in silico and 55 
experimental studies. Assays resulted very accurate and precise with good high repeatability and 56 
reproducibility. Moreover, the two real time assays were very specific for Map, discriminating most 57 
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Mycobacterium avium subspecies paratuberculosis (Map) is an acid-fast mycobactin dependent 72 
pathogen that causes a chronic progressive granulomatous enteritis known as paratuberculosis or 73 
Johne’s disease (JD) (Whittington and Sergeant 2001). Its primary hosts are domestic and wild 74 
ruminants, including cattle, sheep and goats (Bauerfeind et al. 1996). It is estimated that about 40% 75 
of United States herds are infected with Map, resulting in considerable economic losses to the dairy 76 
industry totalling more than $200 million per annum. 77 
Clinical signs similar to those of paratuberculosis in ruminants are characteristic for Crohn’s 78 
disease (CD) in humans. CD is a chronic inflammation of distal intestines exhibiting a pathology 79 
similar to that of JD in ruminants. This has led to the hypothesis that Map could play a role in the 80 
development of CD (Ayele et al. 2001; Feller et al. 2007; Skovgaard 2007; Uzoigwe et al. 2007; 81 
Behr and Kapur 2008). The prevalence of  CD is estimated to be 0.15% among the United States 82 
population resulting in substantial morbidity and medical costs (Ashford et al. 2001). Due to its 83 
reported isolation from pasteurised milk and the potential for transmission of Map through 84 
environmental sources, rapid detection is fundamental. A number of conventional PCR assays 85 
specific for Map detection have been described (Grant et al. 2000; Corti and Stephan 2002; Pillai 86 
and Jayarao 2002; O’Mahony and Hill 2004). Most of these PCR methods target the insertion 87 
sequence 900 (IS900), a species-specific insertion element in Map, which has mostly been accepted 88 
as a standard marker (Green et al. 1989; Vary et al. 1990; De Lisle et al. 1992; McFadden et al. 89 
1992; Bauerfeind et al. 1996; Millar et al., 1996; Portillo et al. 1996; Stevenson and Sharp 1997; 90 
Secott et al. 1999; Bull et al. 2000; Coetsier et al. 2000; Grant et al. 2000; Marsh et al. 2000; Corti 91 
and Stephan 2002; Pillai and Jayarao 2002). However, several publications report the presence of 92 
IS900-like sequences in other closely related environmental mycobacterial species, which could 93 
negatively affect the specificity of PCR assays (Cousins et al. 1999; Englund et al. 2002). In the 94 
past few years, other Map-specific genetic elements have been described at low copy numbers. 95 
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These elements include mainly the F57 sequences (Poupart et al. 1993; Tasara and Stephan 2005; 96 
Herthnek and Bölske 2006). These sequences have been found only in Map making them a 97 
potentially specific target and, although F57 sequences may not be as sensitive as the multicopy 98 
IS900 elements, they are highly specific for Map making them less prone to false-positive results 99 
(Poupart et al. 1993; Coetsier et al. 2000; Vansnick et al. 2004; Tasara et al. 2005).  100 
In this study, we have developed two specific and sensitive real time quantitative PCR (qPCR) 101 
assays targeting IS900 genetic insertion sequence and F57 sequence for detection and quantification 102 




















2. Materials and methods 122 
 123 
2.1. Bacterial and viral isolates 124 
Prototype M. avium subsp. paratuberculosis (Map) was obtained from the American Type Culture 125 
Collection (ATCC, Manassas, VA). M. avium subsp. paratuberculosis strain ‘Linda’ (ATCC 126 
43015), originally isolated from a patient with CD, was incubated at 37°C for 10 weeks in the 127 
ATCC Medium prepared by adding to Middlebrook 7H9 Broth (Difco Laboratories, Detroit, 128 
Mich.): agar technical (14 g/l; SIFIN, Berlin, Germany), tween 80 (0.5 g/l; Sigma Chemical Co., St. 129 
Louis, Mo.), mycobactin J (2 mg/l; Allied Monitor, Fayette, MO, USA) and Dubos Oleic Albumin 130 
Complex (100 ml/l; Difco Laboratories), as described by ATCC Product Information Sheet. Single 131 
colonies were observed after four weeks. To evaluate the specificity of the Map real time qPCR 132 
assays which we developed, purified DNA templates from eight Map isolates, five non-Map 133 
Mycobacterium spp. isolates, and 10 non-Mycobacterium spp. and viral isolates were used for 134 
inclusivity and exclusivity testing (Table 1A and 1B). 135 
 136 
2.2. DNA extraction 137 
After the growth of Map colonies, nucleic acid of a single Map colony was isolated by the 138 
DNeasy® Blood & Tissue Kit (Qiagen, Hilden, Germany) according to the modified protocol 139 
“Purification of total DNA from animal blood or cells (Spin-Column Protocol)”, listed in the 140 
manufacturer’s handbook. As a modification, a mechanical lysis step was included in the original 141 
protocol. In particular, lysis efficiency was improved by colony disruption using the rotor-stator 142 
homogenizer TissueRuptor (Qiagen). Briefly, colonies were harvested into 180 µl of buffer ATL 143 
(Tissue Lysis Buffer, Qiagen) and homogenized using the rotor-stator homogenizer TissueRuptor 144 
(Qiagen) for 30 s to obtain a homogeneous mixture. Twenty microliters of proteinase K (2mg/ml) 145 
were added, followed by vigorous vortex. After incubation at 56°C for 60 min, 200 µl of buffer AL 146 
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and 200 µl of ethanol were added; the combination was vortex mixed thoroughly. Subsequently, the 147 
entire mixture was loaded on a DNeasy mini column and centrifuged for 1 min at 6,000 x g. The 148 
column was washed once with buffers AW1 and AW2, respectively, and DNA was eluted 2 times 149 
each with 200 µl buffer AE. 150 
 151 
2.3. Primers and probes for IS900 and F57 real time qPCR assays 152 
Specific real time qPCR primers for the IS900 and F57 fragment and probes were designed using 153 
Primer Express Software Version 3.0 (Applied Biosystems, Cheshire, United Kingdom). Probes 154 
were labeled with the fluorescent reporter dye 6-carboxyfluorescein (FAM) on the 5’ end and with 155 
the quencher dye N’, N’, N’, N’-tetramethyl-6-carboxyrhodamine (TAMRA) on the 3’ end. Primers 156 
and probes were aliquoted to a final concentration of 10 pmol/µl and stored at -20°C. The primers 157 
and probes used in this study are shown in Table 2.   158 
 159 
2.4. IS900 and F57 real time qPCR assays  160 
The conditions for the IS900 and F57 real time qPCR assays were optimised until the best primer 161 
and probe concentrations and cycling conditions were determined. Real time qPCR assays were 162 
performed using the Platinum qPCR SuperMix-UDG containing ROX as a passive reference 163 
(Invitrogen). IS900- and F57-specific forward primers, reverse primers and probes were used at the 164 
optimized concentration of 0.2 µM, 0.2 µM and 0.1 µM, respectively. Five microliters of DNA 165 
were added to 15 µl of the reaction mix, giving a final reaction concentration of 20 µl. Uracil-DNA 166 
glycosylase was used to eliminate PCR contamination from previous PCR reactions. Real time 167 
qPCR assays were performed using the 7500 Real Time PCR System (Applied Biosystems) 168 
instrument. Cycling conditions to optimize amplification profile included an initial decontamination 169 
at 50°C for 2 min, denaturation step at 95°C for 10 min in order to activate DNA polymerase and an 170 
amplification that was performed during 45 cycles including denaturation (95°C for 15 s), annealing 171 
and extension (60°C for 1 min). The cycle number during which the fluorescence signal is above 172 
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the background (Ct) is proportional to the initial log concentration of the target DNA. Analysis of 173 
the real time qPCR assays was performed using the RTS Analysis Software 2.0 (Applied 174 
Biosystems).  175 
 176 
2.5. Specificity of real time qPCR assays 177 
The specificity of the developed real time qPCR assays was verified by in silico studies (analytical 178 
specificity) against publicly available sequence databases (BLAST alignment software 179 
(www.ncbi.nlm.nih.gov/blast/) to evaluate possible cross-reactions with non-mycobacterial species 180 
and viral isolates. Experimental specificity was also verified. In particular, non-Mycobacterium spp. 181 
and viral sequences of different isolates were used for exclusivity testing (Table 1B). Cross-182 
reactions with human DNA sequences were excluded by testing the primers against preparations of 183 
human nucleic acids.  184 
 185 
2.6. Preparation of quantification standards for sensitivity of qPCR assays 186 
Map purified DNA concentration was spectrophotometrically estimated at OD260 by using a high-187 
resolution spectrometer. The Map DNA concentration value was 93.8 ng/µl. The exact Map 188 
genome copy number was calculated from the molecular weight of Map DNA (3,187,655,460 MW) 189 
and Avogadro number (6.023 x 1023) to obtain stock preparations containing 107 genomic DNA 190 
copies in one microliter. Stock preparations at 2 × 106 copies/μl were diluted to 2 × 10-1 copies/μl 191 
by a series of 10-fold dilutions. To determine the sensitivity of the PCR assays, we have used 192 
genomic DNA dilutions (from 2 × 106 copies/μl to 2 × 10-1 copies/μl) to estimate the dynamic 193 
range. Efficiency, defined as the rate of amplification that leads to a theoretical slope of 3.32 with 194 
an efficiency of 100% in each cycle, was also evaluated. Efficiency can be calculated by the 195 
following equation: 10(-1/slope) (Rasmussen et al. 2001). For storage, dilutions of the standards were 196 
frozen in aliquots, and when needed, the aliquots were thawed before use and than stored at 4C° 197 
during use. 198 
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 199 
2.7. Validation and standardisation of IS900 and F57 real time qPCR assays 200 
To determine the performance of IS900 and F57 assays, we assessed the diagnostic trueness, 201 
precision and accuracy of the techniques. In particular, precision was assessed by evaluating 202 
repeatability and intermediate reproducibility of IS900 and F57 assays. To determine the 203 
repeatability, several replicates containing the various amounts of Map DNA were tested. The 204 
repeatability was determined by 10-fold serial dilutions of the IS900 and F57 quantification 205 
standards. In particular, we used four different dilutions (102, 103, 104, 105 copies/reaction) of 206 
quantification standards. Each dilution was analysed ten times, with the same method on identical 207 
test items in the same laboratory by the same operator using the same equipment. As concern 208 
intermediate reproducibility, each dilution was analysed with the same method on identical test 209 
items in ten different runs performed by three different operators using different equipment on 210 
different days. Moreover, we used the Dixon’s test to examine if one measure from ten replicate 211 
measures that we performed (102, 103, 104, 105), could be rejected or not and the Shapiro-Wilk’s 212 
test to compare these measures against the Normal distribution. Statistical data analysis were 213 
performed using the PASW Statistics 18.0 (SPSS Statistics) software. 214 
 215 
2.8. Clinical specimens 216 
To verify whether the developed assays could be of practical use, a total of 10 colonic mucosal 217 
biopsy specimens were analysed by IS900 and F57 real time qPCR assays. In particular, specimens 218 
consisted of 5 colonic biopsies from patients with CD, and 5 biopsy samples from patients with 219 
colon carcinoma (control group). The case definition of CD was established on the basis of 220 
standard clinical, radiological, endoscopic, and histopathological criteria. The CD group 221 
consisted of 5 Italian patients (4 males, 1 female; median age, 36 years, range, 28-43) with 222 
endoscopically active inflammatory disease. None of the patients were receiving anti-Map 223 
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treatment. The control group comprised 5 Italian patients (2 males, 3 females; median age, 57 224 
years, range, 47-70) with colon carcinoma who did not have a clinicopathological diagnosis of 225 
CD; only specimens of normal colon outside the area with cancer or dysplastic lesions were 226 
considered. None of the individuals in the control group was receiving antibiotics. A number of 227 
precautions were undertaken to prevent the occurrence of false-positive results. Each run included 228 
control reactions lacking template (no-template controls) to test for the presence of contamination 229 
or the generation of non-specific amplification products under the assay conditions used. The 230 
















3. Results 246 
 247 
3.1. Sensitivity of IS900 and F57 real time qPCR assays 248 
Optimal real time qPCR assay conditions that allowed efficient amplification of the IS900 and F57 249 
target sequence were established. In particular, efficiency and sensitivity of IS900 and F57 real time 250 
qPCR assays were assessed by repeated testing of serial logarithmic dilutions of the quantification 251 
standards copies. After real time qPCR amplification, the Ct value (crossing point of the 252 
amplification curve with the pre-set threshold of fluorescence detection) of individual dilution steps 253 
was plotted against the initial bacterium copy number, leading to a typical standard curve. To 254 
examine the dynamic range (range of concentrations over which the method performs in a linear 255 
manner with an acceptable level of trueness and precision) of IS900 and F57 genes quantification 256 
by real time qPCR, serial dilutions of the quantification standard ranging from 107 to 1 257 
copies/reaction were carried out. As shown in Fig. 1, IS900 real time qPCR assay was able to 258 
quantify from 107 to 1 copies/reaction, whereas F57 real time qPCR assay was able to quantify from 259 
107 to 10 copies/reaction. The consistency of replicates was measured by the correlation coefficient 260 
(R2), which indicates the linearity of Ct values plotted in the standard curves. The R2 index for 261 
IS900 and F57 genes was 0.999 and 0.996, respectively and the standard curve slope was 3.461 and 262 
3.383, respectively. Sensitivity of real time qPCR assays was determined by the lowest standard 263 
dilution consistently detectable in replicate reactions at frequency of 100%. IS900 and F57 264 
sensitivity was 1 copy/reaction and 10 copies/reaction, respectively. Efficiency reflects the quality 265 
of the real time qPCR and can be calculated from a standard curve generated using the 266 
concentration of the quantification standard serial dilutions. The efficiency of the reaction is 267 
considered acceptable if it falls between the range of 1.7 and 2.2, with 2 being ideal. The efficiency 268 
of our two real time qPCR assays was 1.9 for IS900 and 2 for F57.   269 
 270 
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3.2. Validation and standardisation of IS900 and F57 real time qPCR assays 271 
Diagnostic trueness of IS900 and F57 real time qPCR methods, defined as the degree of agreement 272 
between the average value obtained from a large series of test results and an accepted reference 273 
value, was evaluated. To establish the level of trueness and concordance with the assigned value, 274 
data from ten replicate measures of each dilution that we performed (102, 103, 104, 105) were 275 
analyzed using a Student’s t-test to compare the mean concentrations from each dilution to an 276 
accepted reference value. The mean concentrations from each dilution for the two methods, are 277 
shown in Table 3 with the t-test results, which indicate the significance of the differences between 278 
each experimental mean and the assigned value. Analysis of the t-statistics showed that both 279 
methods had t-calc values lower than the t-tab value, demonstrating a significant trueness of  IS900 280 
and F56 assays.  281 
Precision of methods was expressed as the coefficient of variation (CV) in the log10 values of the 282 
concentration. Repeatability and intermediate reproducibility of IS900 and F57 assays were 283 
evaluated over different concentrations ranging from 102 to 105 copies/reaction from ten replicate 284 
measures (n=10) of each reference bacterial quantification standard within a single run or in ten 285 
different run experiments performed by three different operators. The precision associated with 286 
each dilution measurement (102, 103, 104, 105) was assessed by calculation of the CV for each. The 287 
coefficients of variation within a single run (repeatability) ranged from 2,99% 18,57% whereas the 288 
coefficients of variation in different runs (intermediate reproducibility) ranged from 4,8% to 40,1% 289 
(Table 3).  290 
Diagnostic accuracy includes both, trueness and precision. The measure of accuracy is usually 291 
expressed numerically in terms of bias (lack of agreement). Accuracy shall be within ±25% of the 292 
accepted reference value over the whole dynamic range. Data for the percentage of inaccuracy 293 
IS900 and F57 methods are reported in Table 3. 294 
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 295 
3.3. Specificity of real time qPCR assays 296 
The ‘nucleotide-nucleotide’ search for nucleotide sequences performed at the National Center for 297 
Biotechnology Information and the National Library of Medicine web site confirmed that the 298 
primer pairs used amplify the following Map sequences: (accession numbers GQ144322.1, 299 
FJ775182.1, FJ775181.1, EU714038.1, EU057175.1, EU057174.1, EU057173.1, EU057172.1, 300 
EU057171.1, EU057170.1, EU057169.1, EU057168.1, EU057167.1, EU057166.1, EU057165.1, 301 
EU057164.1, EU057158.1, EU057157.1, EU057156.1, EU057155.1, EU057153.1, EU232753.1, 302 
EU232752.1, EU232748.1, EU232747.1, EU130943.1, EF514833.1, EF514831.1, EF514829.1, 303 
EF514828.1, EF514825.1, EF514824.1, EF514818.1, EF536058.1, EF536056.1, EF536055.1, 304 
EF536048.1, EF536047.1, EF536046.1, EF536044.1, EF536043.1, EF536042.1, EF536041.1, 305 
EF536040.1, EF536039.1, EF536038.1, EF015397.1, S74401.1, AF416985.1, AF305073.1, 306 
AJ250018.1, AJ250015.1, AJ011838.1, AY974348.1, AY974347.1, AE016958.1, AB052552.1, 307 
AJ250023.1, AJ251437.1, AJ251436.1, AJ251435.1, AJ251434.1, AJ250022.1, AJ250021.1, 308 
AJ250020.1, AJ250019.1, AJ250017.1, AJ250016.1, X16293.1, AY974346.1, AY974345.1, 309 
EU714041.1, EU714039.1, EU714037.1, EU714035.1, AF455252.1, as concerns IS900 sequences 310 
and GQ140314.1, EU379657.1, AE016958.1, X70277.1, as concerns F57 sequences) and do not 311 
amplify other bacteria pathogenic to humans. Moreover, IS900 and F57 primer and probe sets, 312 
tested on Map isolates, were able to detect only their respective subspecies genomes, thus being the 313 
inclusivity of 100% (Table 1A). The assay’s specificity was further demonstrated by its ability to 314 
exclude all non-M. avium subsp. paratuberculosis bacterial species and viral isolates listed in Table 315 
1. No positive results were demonstrated for the other bacterial and viral isolates indicating that 316 
these molecular assays are highly specific for Map isolates, thus being the exclusivity of 100% 317 
(Table 1B). 318 
 319 
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3.4. Detection of Map-DNA in clinical specimens  320 
Map-DNA was detected separately and concordantly in 60% (3/5) of patients with CD and in 321 
0% (0/5) of control group by both IS900 and F57 real time qPCR assays. Therefore, the two 322 
developed methods were in agreement. All negative control reactions were PCR negative, 323 




















4. Discussion 343 
 344 
Map represents an important pathogen for the dairy industry around the world. The difficulties 345 
involved in detecting and enumerating this organism are well known. Currently, there is no 346 
reliable approach of determining the total number of Map cells. In fact, conventional plating 347 
of Map cells and the counting of colonies is not accurate because the Map cells forms clusters 348 
and the number colonies does not reflect the real number of cells. Traditional diagnostic 349 
methods include culture of clinical samples (especially feces and tissue) and serologic tests. 350 
Although culture is considered the gold standard, this method is fraught with difficulties. Some of 351 
the major difficulties of working with Map are its slow growing nature and fastidious nutritional 352 
requirements. The microorganism takes at least 12 to 16 weeks to grow to detectable levels, and 353 
even the most sensitive culture methods have only 50% sensitivity. In addition, the chemical 354 
decontamination steps, used before cultivation to prevent culture overgrowth by competing 355 
microflora present in samples, could inactivate Map, with further reduction of  its diagnostic value 356 
(Chiodini et al. 1984; Stabel et al. 2002; Feller et al. 2007). Immunological-based detection 357 
methods are faster than culture methods but are hampered by low sensitivity and cross-reactivity 358 
problems (Ferreira et al. 2002). In particular, serologic tests, such as enzyme-linked immunosorbent 359 
assays (ELISA), complement fixation (CF) and agar gel immunodiffusion (AGID), are limited in 360 
their use because of low specificity and sensitivity (Nielsen et al. 2000; Kalis et al. 2002; Stabel et 361 
al. 2002). Seroconversion, in fact, occurs relatively late during the course of the disease. In 362 
particular, ELISA can be performed in few hours, but their sensitivity is estimated at 45% since 363 
antibodies may not be detectable until late in infection (Nielsen et al. 2002). Therefore, sensitive 364 
and specific PCR assays for detection of Map could contribute immensely to research efforts aimed 365 
at understanding the potential role of this organism in human CD and its transmission by milk 366 
product. Rapid real time assays are becoming increasingly popular where fast and accurate 367 
diagnosis of Map is required. Currently, several Map detection PCR methods are widely available, 368 
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but practical limitations remain. First of all, detection of Map isolates has been based mainly on 369 
IS900 PCR methods (Millar et al. 1996; Corti and Stephan 2002; Kim et al. 2002; Pillai and Jayarao 370 
2002; Rodrìguez-Làzaro et al. 2005; Herthnek and Bölske 2006). IS900 is defined as a 1,451-bp 371 
multicopy element inserted into 14 to 18 conserved loci in the Map genome and different studies 372 
suggested that it was exclusively present in Map (Green et al. 1989). Hence, IS900 has been the 373 
marker of choice for most molecular assays. However, as IS900-like sequences have been 374 
demonstrated in other unrelated Mycobacterium species, it is evident that the PCR systems used for 375 
IS900 are not completely specific for Map. This evidence has resulted in doubts concerning the 376 
current Map detection methods (Roiz et al. 1995; Cousins et al. 1999). It is therefore desirable to 377 
use alternative IS900 PCR systems to confirm a positive PCR for Map. Therefore, because of the 378 
importance of distinguishing these related mycobacteria, there is a need of adding other molecular 379 
targets to IS900 sequence to confirm the presence of Map. In the present study we successfully 380 
developed and optimised two independent real time quantitative PCR (qPCR) assays able to detect 381 
both IS900 and F57 elements. In contrast to IS900, F57 has no known similarities to genes on other 382 
related organisms, which made the task of selecting suitable oligos for F57 less complicated. In 383 
particular, F57 sequence is a genetic element that is currently known to exist only in Map and that 384 
so far has been found to be highly specific. Therefore, the identification of this DNA sequence 385 
considered to be unique to Map, offers additional tools for rapid identification of this organism. 386 
Plus, previous works have shown that Map is very difficult to detect reliably and reproducibly by 387 
PCR methods (Naser et al. 1999). In particular, different critical steps in the DNA extraction 388 
procedure were found to be of importance. In fact, Map cells are structurally complex and must be 389 
efficiently lysed to release as much of the target DNA molecules as possible. We used a DNA 390 
extraction procedure that was rapid and able to obtain a high-quality Map DNA. This protocol was 391 
a modified protocol that combined mechanical lysis and subsequent template purification using 392 
nucleic acid binding columns. By integrating the optimised Map DNA extraction procedure and 393 
optimised IS900 and F57-based primer and probe concentrations and cycling conditions, we 394 
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obtained two independent real time quantitative PCR assays very sensitive and specific able to 395 
detect DNA Map. In particular, the sensitivity of the IS900 assay was shown to range from 1 to 107 396 
copies/reaction, whereas F57 real time qPCR assay was able to quantify from 10 to 107 397 
copies/reaction.  398 
Diagnostic trueness, precision and accuracy of the developed methods was also evaluated. Both 399 
IS900 and F57 assays resulted very accurate and precise with good high repeatability and 400 
reproducibility as reflected by the CV results (Table 3). Moreover, the two real time assays that we 401 
developed were very specific for Map, discriminating most of mycobacterial species and non-402 
mycobacterial species employed in this study.  403 
In summary, we have presented two rapid, sensitive and specific real time qPCR assays that can be 404 
used to quantify DNA Map. The IS900 and F57 real time qPCR assays that we developed could be 405 
useful to enlarge the spectrum of available Map detection methods and contribute to the routine 406 
detection of this organism as valuable tools in the molecular diagnostics of Map. In conclusion, 407 
after validation on several mycobacterial strains and clinical samples, our molecular assays were 408 
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Table 1. Evaluation of real time PCR specificity with Mycobacterium avium subsp. 594 
paratuberculosis and non-Mycobacterium avium subsp. paratuberculosis strains and viral isolates. 595 





    
 
IS900  F57 
M. avium subsp. paratuberculosis 
strain Linda (human) ATCC 43015 + 
 
+ 
M. avium subsp. paratuberculosis 
strain 5617 (bovine) ATCC 19698  + 
 
+ 
M. avium subsp. paratuberculosis 
strain NCTC 8578 (cow) ATCC 19851 
 
+ + 
M. avium subsp. paratuberculosis 
strain Ben (human) ATCC 43544 
 
+ + 
M. avium subsp. paratuberculosis 
strain Dominic (human) ATCC 43545 
 
+ + 
M. avium subsp. paratuberculosis 
strain Holland-1 (human) ATCC 49164 
 
+ + 
M. avium subsp. paratuberculosis 





M. avium subsp. paratuberculosis 













     IS900  F57 
Mycobacterium bovis ATCC 27289 - - 
Mycobacterium microti ATCC 11152 - - 
Mycobacterium tuberculosis ATCC 25177 - - 
Mycobacterium africanum ATCC 25420 - - 
Mycobacterium caprae ATCC BAA-824 - - 
E. coli ATCC 11605 - - 
Streptococcus agalactiae ATCC 13813 - - 
Staphylococcus aureus ATCC 10832 - - 
Enterobacter cloacae ATCC 10699 - - 
Bacillus cereus ATCC 10987 - - 
Salmonella enterica ATCC 10398 - - 
Virus  - - 
Coxsackievirus ATCC VR-1005PI/MK - - 
Echovirus ATCC VR-1038 - - 
Enterovirus ATCC VR-1077 - - 
Adenovirus ATCC VR-1086 - - 
 603 






Table 2. PCR primer and probe sequences to amplify the multicopy element IS900 and the single 609 
copy element F57 of Mycobacterium avium subsp. paratuberculosis. 610 
 611 




IS900QF CCGGTAAGGCCGACCATTA 67 
IS900QR ACCCGCTGCGAGAGCA 
IS900QP FAM-CATGGTTATTAACGACGACGCGCAGC-TAMRA 


























105   
IS900-Trueness (t-test):     
experimental mean concentration 108,9701215 1057,173703 10976,67223 109851,658 
standard deviation 8,935402709 107,3067791 1521,132919 8549,866926 
t-calc 2,2447563 1,191390579 1,435709845 2,576528626 
t-tab (n=10) 2,776 2,776 2,776 2,776 
F57-Trueness (t-test):     
experimental mean concentration 83,00521733 900,4376291 9942,589826 100414,7937 
standard deviation 15,41613442 93,53565816 1110,845071 3006,841907 
t-calc 2,465046573 2,380142863 0,115563417 0,30846549 
t-tab (n=10) 2,776 2,776 2,776 2,776 
IS900-Precision 
 (% coefficient of variation, CV): 
    
repeatability 8,199864865 10,1503451 13,85786955 7,783102308 
intermediate reproducibility 21,05633093 17,19892394 25,92358547 10,8523951 
F57-Precision 
 (% coefficient of variation, CV): 
    
repeatability 18,57248847 10,38779979 11,17259276 2,994421236 
intermediate reproducibility 40,13820884 15,26099457 21,70100988 4,805707451 
IS900-Accuracy (% bias inaccuracy): 8,970121537 5,717370267 9,766722338 9,851657958 
F57-Accuracy (% bias inaccuracy): 16,99478267 9,956237086 0,574101744 0,414793723 
 624 
 625 
